Unresectable or metastatic melanoma with BRAF V600E mutation
Renal Dose Adjustment
Hepatic Dose Adjustment
Tafinlar interacts with :
Pregnancy Category:D
Breastfeeding: Safety unknown. As many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother
US Trade Name(s)
US Availability
Tafinlar
Canadian Trade Name(s)
Canadian Availability
UK Trade Name(s)
UK Availability
Australian Trade Name(s)
Australian Availability